LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...
Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...
LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company ...
26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are owned ...
(MENAFN- Investor Brand Network) Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective ...
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing ...
Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the“Company”) (NASDAQ: VVOS) , a medical technology company specializing in the development and commercialization of ...
Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos” or the "Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of highly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback